Rocuronium Bromide: Uses, Dosage, Side Effects | MedexInfo
Rocuronium Bromide
Rx Only
Generic NameRocuronium Bromide
Therapeutic ClassNon-depolarizing Neuromuscular Blocker
Common Dose0.6 mg/kg IV (intubation)
Max / 24hBased on clinical need
PregnancyCategory B
Indications ▼
Facilitation of tracheal intubation during routine and rapid-sequence induction
Maintenance of skeletal muscle relaxation during surgery
Facilitation of mechanical ventilation in ICU settings
Mechanism & Pharmacokinetics ▼
Mechanism: Competitively blocks acetylcholine at nicotinic receptors at the neuromuscular junction, preventing depolarization and causing muscle paralysis.
Pharmacokinetics: Rapid onset (1–2 minutes); duration 30–60 minutes; primarily hepatic metabolism and biliary excretion; elimination half-life ~1–2 hours.
Dosage & Administration ▼
| Patient Category | Recommended Dose | Max / 24h |
|---|---|---|
| Adults (Intubation) | 0.6 mg/kg IV bolus | Based on procedure |
| Rapid Sequence Induction | 1–1.2 mg/kg IV | Based on procedure |
| Maintenance Dose | 0.1–0.2 mg/kg IV as needed | Based on clinical response |
| Pediatric | 0.6–1 mg/kg IV | Based on weight |
Note: Administer only by trained anesthesia personnel. Continuous monitoring of neuromuscular function and respiratory support is required.
Side Effects ▼
Common: Injection site reactions, transient hypotension
Occasional: Tachycardia, bronchospasm
Serious: Prolonged paralysis, anaphylaxis
Contraindications ▼
Known hypersensitivity to rocuronium or other neuromuscular blockers
Use cautiously in patients with neuromuscular disorders
Drug Interaction ▼
Enhanced effect with inhalational anesthetics
Aminoglycosides may potentiate neuromuscular blockade
Reversal agents: Sugammadex or Neostigmine
Pregnancy & Lactation ▼
Category B; use if clearly needed
Limited data in breastfeeding; use caution
Clinical / Research Summary ▼
Rapid onset makes it suitable for rapid-sequence intubation
Intermediate duration of action
Reversible with sugammadex providing rapid recovery
Widely used alternative to succinylcholine
Patient Counseling Points ▼
Administered only in hospital settings
Requires ventilatory support until recovery
Patients should inform anesthesiologist about allergies or neuromuscular disorders
Storage & Handling ▼
Store at 2–8°C (refrigerated)
Do not freeze; protect from light
Brand Names (Bangladesh & Global) ▼
Medical Disclaimer: This information is for educational purposes only and should not replace professional medical advice.
Esmeron® 50 mg/5 ml